Zobrazeno 1 - 10
of 574
pro vyhledávání: '"Bugajska-Schretter A"'
Autor:
Vanessa Monteil, Brett Eaton, Elena Postnikova, Michael Murphy, Benedict Braunsfeld, Ian Crozier, Franz Kricek, Janine Niederhöfer, Alice Schwarzböck, Helene Breid, Stephanie Devignot, Jonas Klingström, Charlotte Thålin, Max J Kellner, Wanda Christ, Sebastian Havervall, Stefan Mereiter, Sylvia Knapp, Anna Sanchez Jimenez, Agnes Bugajska‐Schretter, Alexander Dohnal, Christine Ruf, Romana Gugenberger, Astrid Hagelkruys, Nuria Montserrat, Ivona Kozieradzki, Omar Hasan Ali, Johannes Stadlmann, Michael R Holbrook, Connie Schmaljohn, Chris Oostenbrink, Robert H Shoemaker, Ali Mirazimi, Gerald Wirnsberger, Josef M Penninger
Publikováno v:
EMBO Molecular Medicine, Vol 14, Iss 8, Pp 1-13 (2022)
Abstract The recent emergence of multiple SARS‐CoV‐2 variants has caused considerable concern due to both reduced vaccine efficacy and escape from neutralizing antibody therapeutics. It is, therefore, paramount to develop therapeutic strategies t
Externí odkaz:
https://doaj.org/article/8b99883b78934b478c6d1c13c62796ff
Autor:
Rudolf Valenta, Susanne Vrtala, Margit Focke-Tejkl, Anna Twardosz, Ines Swoboda, Agnes Bugajska-Schretter, Susanne Spitzauer, Dietrich Kraft
Publikováno v:
Inflammatory Mechanisms in Allergic Diseases ISBN: 9780429134432
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32fe3887b3a6d1026d0798262e907760
https://doi.org/10.1201/9780429134432-27
https://doi.org/10.1201/9780429134432-27
Autor:
Monteil, Vanessa, Eaton, Brett, Postnikova, Elena, Murphy, Michael, Braunsfeld, Benedict, Crozier, Ian, Kricek, Franz, Niederhöfer, Janine, Schwarzböck, Alice, Breid, Helene, Devignot, Stephanie, Klingström, Jonas, Thålin, Charlotte, Kellner, Max J, Christ, Wanda, Havervall, Sebastian, Mereiter, Stefan, Knapp, Sylvia, Sanchez Jimenez, Anna, Bugajska‐Schretter, Agnes, Dohnal, Alexander, Ruf, Christine, Gugenberger, Romana, Hagelkruys, Astrid, Montserrat, Nuria, Kozieradzki, Ivona, Hasan Ali, Omar, Stadlmann, Johannes, Holbrook, Michael R, Schmaljohn, Connie, Oostenbrink, Chris, Shoemaker, Robert H, Mirazimi, Ali, Wirnsberger, Gerald, Penninger, Josef M
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
EMBO Mol Med.
Dipòsit Digital de la UB
Universidad de Barcelona
article-version (status) pre
article-version (number) 1
EMBO Mol Med.
Dipòsit Digital de la UB
Universidad de Barcelona
The recent emergence of multiple SARS-CoV-2 variants has caused considerable concern due to reduced vaccine efficacy and escape from neutralizing antibody therapeutics. It is therefore paramount to develop therapeutic strategies that inhibit all know
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70de52e686744328648861546d422fbe
http://hdl.handle.net/2445/187538
http://hdl.handle.net/2445/187538
Autor:
M. Kuttke, R. Gugenberger, K. Thell, S. Bischof, B. Peball, H. Muehleisen, M. Urban, B. Gapp, A. Bugajska-Schretter, A. Halfmann, P. Morley, A. Dohnal
Publikováno v:
ESMO Open. 8:100981
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2a176f29bde9b8fd27e93dd5d2ce31a
https://doi.org/10.1016/j.esmoop.2023.100981
https://doi.org/10.1016/j.esmoop.2023.100981
Autor:
Kritsch, Constantia E. *, Berger, Agnes, Heinrich-Cseh, Christa, Bugajska-Schretter, Agnes, Zauner, Wolfgang
Publikováno v:
In Journal of Chromatography B 2005 822(1):263-270
Autor:
Monteil V; Unit of Clinical Microbiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Eaton B; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, Maryland, USA., Postnikova E; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, Maryland, USA., Murphy M; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, Maryland, USA., Braunsfeld B; Institute for Molecular Modeling and Simulation, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria., Crozier I; Clinical Research Monitoring Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Kricek F; NBS-C BioScience & Consulting GmbH, Vienna, Austria., Niederhöfer J; invIOs, Vienna, Austria., Schwarzböck A; invIOs, Vienna, Austria., Breid H; invIOs, Vienna, Austria., Devignot S; Unit of Clinical Microbiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Klingström J; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden., Thålin C; Department of Clinical Sciences, Karolinska Institute Danderyd Hospital, Stockholm, Sweden., Kellner MJ; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.; Vienna BioCenter PhD Program, Doctoral School of the University at Vienna and Medical, University of Vienna, Vienna, Austria., Christ W; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden., Havervall S; Department of Clinical Sciences, Karolinska Institute Danderyd Hospital, Stockholm, Sweden., Mereiter S; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria., Knapp S; Department of Medicine 1, Laboratory of Infection Biology, Medical University of Vienna, Vienna, Austria., Sanchez Jimenez A; invIOs, Vienna, Austria., Bugajska-Schretter A; invIOs, Vienna, Austria., Dohnal A; invIOs, Vienna, Austria., Ruf C; NBS-C BioScience & Consulting GmbH, Vienna, Austria., Gugenberger R; invIOs, Vienna, Austria., Hagelkruys A; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria., Montserrat N; Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain., Kozieradzki I; Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada., Hasan Ali O; Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada., Stadlmann J; Institute of Biochemistry, Department of Chemistry, University of Natural resources and Life, Sciences (BOKU), Vienna, Austria., Holbrook MR; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, Maryland, USA., Schmaljohn C; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, Maryland, USA., Oostenbrink C; Institute for Molecular Modeling and Simulation, University of Natural Resources and Life Sciences (BOKU), Vienna, Austria., Shoemaker RH; Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Mirazimi A; Unit of Clinical Microbiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Wirnsberger G; invIOs, Vienna, Austria., Penninger JM; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.; Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2022 Aug 08; Vol. 14 (8), pp. e15230. Date of Electronic Publication: 2022 Jul 04.
Autor:
Wirnsberger G; Apeiron Biologics, Vienna, Austria., Monteil V; Karolinska Institutet and Karolinska University Hospital, Unit of Clinical Microbiology, SE-17182, Stockholm, Sweden., Eaton B; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, MD 21702, USA., Postnikova E; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, MD 21702, USA., Murphy M; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, MD 21702, USA., Braunsfeld B; Institute for Molecular Modeling and Simulation, University of Natural Resources and Life Sciences (BOKU), Austria., Crozier I; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, MD 21702, USA., Kricek F; NBS-C BioScience & Consulting GmbH, Vienna, Austria., Niederhöfer J; Apeiron Biologics, Vienna, Austria., Schwarzböck A; Apeiron Biologics, Vienna, Austria., Breid H; Apeiron Biologics, Vienna, Austria., Jimenez AS; Apeiron Biologics, Vienna, Austria., Bugajska-Schretter A; Apeiron Biologics, Vienna, Austria., Dohnal A; Apeiron Biologics, Vienna, Austria., Ruf C; NBS-C BioScience & Consulting GmbH, Vienna, Austria., Gugenberger R; Apeiron Biologics, Vienna, Austria., Hagelkruys A; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria., Montserrat N; Pluripotency for Organ Regeneration, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain., Holbrook MR; NIAID Integrated Research Facility at Fort Detrick (IRF-Frederick), Frederick, MD 21702, USA., Oostenbrink C; Institute for Molecular Modeling and Simulation, University of Natural Resources and Life Sciences (BOKU), Austria., Shoemaker RH; Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892., Mirazimi A; Karolinska Institutet and Karolinska University Hospital, Unit of Clinical Microbiology, SE-17182, Stockholm, Sweden., Penninger JM; Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.; Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2021 Sep 10. Date of Electronic Publication: 2021 Sep 10.
Autor:
Helmut Rumpold, Luca Vangelista, Susanne Spitzauer, Monika Grote, Wolfgang R. Sperr, Rudolf Reichelt, Rudolph Valenta, Agnes Bugajska-Schretter, Annalisa Pastore, Peter Valent
Publikováno v:
Gut. 46:661-669
BACKGROUND—Almost 4% of the population suffer from food allergy which is an adverse reaction to food with an underlying immunological mechanism. AIMS—To characterise one of the most frequent IgE defined food allergens, fish parvalbumin. METHODS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4993a37f1d326caccdc96d56f1d9df52
https://doi.org/10.1136/gut.46.5.661
https://doi.org/10.1136/gut.46.5.661
Autor:
Constantia Kritsch, Wolfgang Zauner, Agnes Bugajska-Schretter, Christa Heinrich-Cseh, Agnes Berger
Publikováno v:
Journal of Chromatography B. 822:263-270
Two reversed-phase HPLC methods were developed for the quantitative determination of the two components of the novel vaccine adjuvant IC31. The adjuvant consists of a mixture of a synthetic oligodeoxynucleotide (ODN) and an 11-mer cationic peptide. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18cc5930640fc7ec3b9bf5c51b6920d0
https://doi.org/10.1016/j.jchromb.2005.06.013
https://doi.org/10.1016/j.jchromb.2005.06.013
Publikováno v:
Allergy. 57:94-96
Fish and fish products represent one of the most important causes of IgE-mediated food hypersensitivity. In sensitized individuals contact with and consumption of fish can lead to severe health problems, ranging from urticaria and dermatitis to angie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0237e41f291bea0f256b2becddb2cad7
https://doi.org/10.1034/j.1398-9995.57.s72.21.x
https://doi.org/10.1034/j.1398-9995.57.s72.21.x